Exact Mass: 283.1321

Exact Mass Matches: 283.1321

Found 34 metabolites which its exact mass value is equals to given mass value 283.1321, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

brevianamide F

C16H17N3O2 (283.1321)

A pyrrolopyrazine that is hexahydropyrrolo[1,2-a]pyrazine-1,4-dione bearing an indol-3-ylmethyl substituent at position 3 (the 3S,8aS-diastereomer, obtained by formal cyclocondensation of L-tryptophan and L-proline). Brevianamide F (Cyclo(L-Pro-L-Trp)) is a mycotoxin isolated from Colletotrichum gloeosporioides, with antibacterial activity. Brevianamide F shows potent PI3Kα inhibitory activity with an IC50 of 4.8 μM[1][2].

Amonafide

11-amino-3-[2-(dimethylamino)ethyl]-3-azatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione

C16H17N3O2 (283.1321)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

Dazmegrel

3-{3-[(1H-imidazol-1-yl)methyl]-2-methyl-1H-indol-1-yl}propanoic acid

C16H17N3O2 (283.1321)

C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

Exact Mass: 283.1321

Exact Mass Matches: 283.1321

brevianamide F

Amonafide

Dazmegrel

Tryptophandehydrobutyrine diketopiperazine

8-Hydroxyergine

8-Hydroxyerginine

Ethyl 5-amino-4-cyano-3-methyl-1-(4-methylphenyl)-1H-pyrrole-2-carboxylate

3-(1H-indol-3-ylmethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

1-[2-(4-METHOXY-PHENOXY)-ETHYL]-1H-BENZOIMIDAZOL-2-YLAMINE

Acetanilide,2,2-iminobis- (8CI)

3-[2-(2-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDIN-6-YL]-PROPAN-1-OL

1-(2-NITROBENZYL)PIPERAZINEDIHYDROCHLORIDE

2-amino-n-furan-2-ylmethyl-3-(1h-indol-3-yl)-propionamide

2-Methoxy-6-[[(1-methylbenzimidazol-2-yl)amino]methyl]phenol

4-Phenyl-2-(piperidin-1-yl)pyrimidine-5-carboxylic acid

5-Methoxy-2-[[(1-methyl-2-benzimidazolyl)amino]methyl]phenol

Amonafide

Dazmegrel

3-(1H-indol-3-ylmethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

3-(5-Tert-butyl-1,2,4-oxadiazol-3-ylidene)-7-methyl-2-quinolinone

1-(1-Benzotriazolyl)-3-(2-methylphenoxy)-2-propanol

2-Amino-9-ethyl-3-pyrido[2,3-b]indolecarboxylic acid ethyl ester

4-[acetyl(methyl)amino]-N-(2-aminophenyl)benzamide

Cyclo(Trp-Pro)

2-(n-hydroxyimino)-3-[7-(3-methylbuta-1,3-dien-1-yl)-1h-indol-3-yl]propanamide

(3r,8as)-1-hydroxy-3-(1h-indol-3-ylmethyl)-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

(3z)-3-ethylidene-5-hydroxy-6-(1h-indol-3-ylmethyl)-1-methyl-6h-pyrazin-2-one

2-hydroxy-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),3,9,12,14-pentaene-4-carboximidic acid

(3e,6s)-3-ethylidene-5-hydroxy-6-(1h-indol-3-ylmethyl)-1-methyl-6h-pyrazin-2-one

(2z)-2-(n-hydroxyimino)-3-{7-[(1e)-3-methylbuta-1,3-dien-1-yl]-1h-indol-3-yl}propanimidic acid

(2s,7r)-2-hydroxy-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),3,9,12,14-pentaene-4-carboximidic acid

2-{[(2-phenylethyl)-c-hydroxycarbonimidoyl]amino}benzenecarboximidic acid

4-hydroxy-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid

1-hydroxy-3-(1h-indol-3-ylmethyl)-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one